796 related articles for article (PubMed ID: 19125547)
41. Outcomes of a Medicare Part D telephone medication therapy management program.
Moczygemba LR; Barner JC; Gabrillo ER
J Am Pharm Assoc (2003); 2012; 52(6):e144-52. PubMed ID: 23229976
[TBL] [Abstract][Full Text] [Related]
42. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services.
Shoemaker SJ; Hassol A
J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775
[TBL] [Abstract][Full Text] [Related]
43. Medication therapy management and condition care services in a community-based employer setting.
Johannigman MJ; Leifheit M; Bellman N; Pierce T; Marriott A; Bishop C
Am J Health Syst Pharm; 2010 Aug; 67(16):1362-7. PubMed ID: 20689127
[TBL] [Abstract][Full Text] [Related]
44. Perceived value of a home-based medication therapy management program for the elderly.
Moultry AM; Poon IO
Consult Pharm; 2008 Nov; 23(11):877-85. PubMed ID: 19072012
[TBL] [Abstract][Full Text] [Related]
45. Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program.
Taylor AM; Bingham J; Schussel K; Axon DR; Dickman DJ; Boesen K; Martin R; Warholak TL
J Manag Care Spec Pharm; 2018 Aug; 24(8):813-818. PubMed ID: 30058982
[TBL] [Abstract][Full Text] [Related]
46. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships.
Akers JL; Meer G; Kintner J; Shields A; Dillon-Sumner L; Bacci JL
J Am Pharm Assoc (2003); 2019; 59(2):243-251. PubMed ID: 30638730
[TBL] [Abstract][Full Text] [Related]
47. A structured patient identification model for medication therapy management services in a community pharmacy.
Pagano GM; Groves BK; Kuhn CH; Porter K; Mehta BH
J Am Pharm Assoc (2003); 2017; 57(5):619-623.e1. PubMed ID: 28733156
[TBL] [Abstract][Full Text] [Related]
48. Implementation of technician-driven medication therapy management program in community pharmacies.
Burnside TPT; Scott NJ; Smith MG
J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039
[TBL] [Abstract][Full Text] [Related]
49. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.
Stebbins MR; Kaufman DJ; Lipton HL
J Manag Care Pharm; 2005 May; 11(4):333-41. PubMed ID: 15871644
[TBL] [Abstract][Full Text] [Related]
50. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
Millonig MK
J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
[TBL] [Abstract][Full Text] [Related]
51. Pharmacy technician involvement in community pharmacy medication therapy management.
Lengel M; Kuhn CH; Worley M; Wehr AM; McAuley JW
J Am Pharm Assoc (2003); 2018; 58(2):179-185.e2. PubMed ID: 29396178
[TBL] [Abstract][Full Text] [Related]
52. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.
Hurwitz JT; Grizzle AJ; Augustine J; Rehfeld R; Wild A; Abraham I
J Manag Care Spec Pharm; 2016 Jan; 22(1):40-8. PubMed ID: 27015050
[TBL] [Abstract][Full Text] [Related]
53. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand.
Hansen RA; Roth MT; Brouwer ES; Herndon S; Christensen DB
J Am Pharm Assoc (2003); 2006; 46(6):700-6. PubMed ID: 17176685
[TBL] [Abstract][Full Text] [Related]
54. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
[TBL] [Abstract][Full Text] [Related]
55. Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients.
Twigg G; Motsko J; Thomas J; David T
Consult Pharm; 2017 May; 32(5):299-310. PubMed ID: 28483010
[TBL] [Abstract][Full Text] [Related]
56. Economic viability of tech-check-tech in an independent community pharmacy.
Gatwood J; Martin H; Newsome R; Hohmeier KC
J Am Pharm Assoc (2003); 2019; 59(4):570-574. PubMed ID: 30979577
[TBL] [Abstract][Full Text] [Related]
57. Trends in the medication reviews of community pharmacies in Japan: a nationwide retrospective study.
Koyama T; Onoue H; Ohshima A; Tanaka Y; Tatebe Y; Zamami Y; Shinomiya K; Kitamura Y
Int J Clin Pharm; 2018 Feb; 40(1):101-108. PubMed ID: 29189975
[TBL] [Abstract][Full Text] [Related]
58. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
[TBL] [Abstract][Full Text] [Related]
59. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
60. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
